If You Bought or Provided Reimbursement for the Dry-Eye Disease Drug Restasis® You Could Be Included in a Class Action Lawsuit For more detailed information, visit: www.RestasisLitigation.com Para conseguir una notificación en español, llame a 1-877-868-6810 o visite el sitio web: www.RestasisLitigation.com.
Lieff Cabraser has filed a class action labor antitrust “no-poach” lawsuit against Live Oak Bank and its two tech spin-offs, Apiture and nCino, on behalf of a former employee of two of the companies and at least seven hundred potential class members. As reported by the Triangle Business Journal, the lawsuit alleges that Live Oak’s
Lieff Cabraser partner Katherine Lubin Benson will be moderating a Bar Association of San Francisco Antitrust & Business Regulation Section panel on Wednesday, February 24, 2021 from 12:00 – 1:15 p.m. online via Zoom. The panel, entitled “Big Tech’s Reckoning With Antitrust Has Arrived,” will feature a discussion of the recent government and private actions against
First lawsuit brought by Lieff Cabraser in Germany on behalf of TransAtlantis seen likely to give momentum to cartel damages litigation against the truck cartel January 12, 2021 — Lieff Cabraser’s Munich office is leading aggregate litigation against the infamous European truck cartel of truck manufacturers Daimler, DAF, Iveco, MAN, Volvo/Renault, and Scania. In its
Historic antitrust case against Momenta Pharmaceuticals over illegal drug price-fixing led to second largest indirect purchaser antitrust pharmaceutical settlement in history At a virtual awards ceremony held on November 12, The American Antitrust Institute formally presented its selection of leading legal practitioners and economists to be recognized as honorees for the
On October 15, 2020, Lieff Cabraser filed an amicus brief on behalf of the American Antitrust Institute (AAI), Consumer Reports, and Public Citizen in the U.S. District Court for the Eastern District of California opposing a generic pharmaceutical association’s efforts to defeat pro-consumer anti-pay-for-delay legislation. A legal tactic used by branded drug manufacturers to stifle
Historic antitrust case against Momenta Pharmaceuticals over illegal drug price-fixing led to second largest indirect purchaser antitrust pharmaceutical settlement in history The American Antitrust Institute has announced its selection of leading practitioners and economists to be recognized as honorees for the 2020 Antitrust Enforcement Awards. Lieff Cabraser’s team shared the AAI’s
SAN FRANCISCO–(BUSINESS WIRE)– A federal judge has appointed Lieff Cabraser Heimann & Bernstein, LLP, Cotchett, Pitre & McCarthy, LLP, and Susman Godfrey L.L.P. to lead a class action lawsuit on behalf of indirect purchasers of telescopes against global telescope suppliers for allegedly engaging in a conspiracy to fix prices and allocate the market for telescopes.
Lawsuit alleged the companies agreed to under-the-table and illegal deals to not-hire each other’s employees in order to keep wages and job competition low On August 26, 2020, Judge Joy Flowers Conti of the U.S. District Court for the Western District of Pennsylvania granted final approval to a settlement of the labor antitrust litigation filed
On May 22, 2018, Lieff Cabraser partner Dean M. Harvey discussed competition and antitrust in employment practices at the American Bar Association Antitrust Law Section’s “Tech-Savvy and Talented: Competition in Employment Practices,” teleconference.